Expression of CD133 was considered relates with stronger tumorigenesis invasion, and chemo-radiotherapy resistance in many kinds of cancers, such as liver cancer [26], glioblastoma [27], and pancreatic cancer [28]. The gene discussed is PROM1; the disease is glioblastoma.